Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

A Bioluminescent Cell Viability Assay Optimized for 3D Microtissues

Part # PS210

Abstract

Michael P. Valley, Chad Zimprich, James J. Cali, and Dan F. Lazar
Promega Corporation, 2800 Woods Hollow Road, Madison WI, 53711-5399, USA
AACR 2013 Abstract #5531
Cells assessed in 3D culture models frequently provide more physiologically relevant data than cells studied in standard 2D formats. Thus, there is a need for convenient and effective assays explicitly validated for 3D microtissues. Here we report on CellTiter-Glo® 3D, a bioluminescent ATP detection assay for measuring cell viability with an optimized protocol and an improved formulation that has been expressly designed to measure the viability of 3D microtissues. This single-component liquid reagent has significant lytic capacity, exhibits high ATP recovery, and can be used to measure the viability of microtissues grown in a variety of 3D culture models, including ECM-independent (e.g., hanging drop), ECM-dependent (e.g., Matrigel™), and synthetic scaffolds (e.g., Alvetex™).

Download the poster, below. See also the CellTiter-Glo® 3D product page.

Printed in USA.